Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet

Journal of Dermatological Science

Volumn 14, Issue 3, 1997, Pages 189-198

  Hirao, Tetsuji ^a   Aoki, Hiroe ^a   Ichikawa, Hideyuki ^a   Sato, Yoshihisa ^a  

^a Inst for Adv Skin Research Inc   (Japan)

Author keywords

IL 1ra; Immunosuppression; Interleukin; Ultraviolet

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDERMIS; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION;

ANIMALS; CELL DIVISION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; IMMUNOBLOTTING; IMMUNOSUPPRESSION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; THYMUS GLAND; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 0031106686     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00572-5     Document Type: Article

References (30)

1. [1] Ansel JC, Luger TA, Green I: The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. J Invest Dermatol 81: 519-523, 1983.
2. [2] Ansel JC, Luger TA, Lowry D, Perry P, Roop DR, Mountz JD: The expression and modulation of IL-1α in murine keratinocytes. J Immunol 140: 2274-2278, 1988.
3. [3] Gahring L, Baltz M, Pepys MB, Daynes R: Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro. Proc Natl Acad Sci USA 81: 1198-1202, 1984.
4. [4] Granstein RD, Sauder DN: Whole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. Lymphokine Res 6: 187-193, 1987.
5. [5] Murphy GM, Dowd PM, Hudspith BN, Brostoff J, Greaves MW: Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photodermatology 6: 268-274, 1989.
6. [6] Kupper TS, Chua AO, Flood P, McGuire J, Gubler U: Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 80: 430-436, 1987.
7. [7] Krutmann J, Elmets CA: Recent studies on mechanisms in photoimmunology. Photochem Photobiol 48: 787-798, 1988.
8. [8] Morison WL: Photoimmunology. Photochem Photobiol 40: 781-787, 1984.
9. [9] Streilein JW, Taylor JR, Vincek V, Kurimoto I, Shimizu T, Tie C, Colomb C: Immune surveillance and sunlight induced skin cancer. Immunol Today 1994.
10. [10] Noonan FP, De Fabo EC: Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol Today 13: 250-254, 1992.
11. [11] Chung H-T, Burnham DK, Robertson B, Roberts LK, Daynes RA: Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. J Immunol 137: 2478-2484, 1986.
12. [12] Vermeer M, Streilein JW: Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed 7: 258-265, 1990.
13. [13] Rivas JM, Ullrich SE: Systemic suppression of DTH by supernatants from UV-irradiated keratinocytes: an essential role for interleukin 10. J Immunol 149: 3865-3871, 1992.
14. [14] Ullrich SE: Mechanism in the systemic suppression of antigen-presenting cell function by UV irradiation: keratinocyte-derived IL-10 modulates antigen presenting cell function of splenic adherent cells. J Immunol 152: 3410-3416, 1994.
15. [15] Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341-346, 1990.
16. [16] Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC: Inlerleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 88: 5232-5236, 1991.
17. [17] Gruaz-Chatellard D, Baumberger C, Saurat JH, Dayer JM: Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS Lett 294: 137-140, 1991.
18. [18] Haskill S, Martin G, Le LV, Morris J, Peace A, Bigler CF, Jaffe GJ, Hammerberg C, Sporn SA, Fong S, Arend WP, Ralph P: cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 88: 3681-3685, 1991.
19. [19] Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98: 38-44, 1992.
20. [20] Hirao T, Aoki H, Yoshida T, Sato Y, Kamoda H: Elevation of interleukin 1 receptor antagonist in the stratum corneum of sun-exposed and UVB-irradiated human skin. J Invest Dermatol, 106: 1102-1107, 1996.
21. [21] Mackenzie IC, Squier CA: Cytochemical identification of ATPase-positive Langerhans cells in EDTA-separated sheets of mouse epidermis. Br J Dermatol 92: 523-533, 1975.
22. [22] Gery I, Gershon RK, Waksman BH: Potentiation of the T lymphocyte response to mitogens. I. The responding cell. J Exp Med 136: 128-138, 1972.
23. [23] Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
24. [24] Kaye J, Janeway Jr CA: The Fab fragment of a directly activating monoclonal antibody that participates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia. J Exp Med 159: 1397-1412, 1984.
25. [25] Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, Ooi A, Mai M, Matsushima K: Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 58: 90-98, 1995.
26. [26] Schwarz T, Urbanska A, Gschnait F, Luger TA: UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity. J Immunol 138: 1457-1463, 1987.
27. [27] Schwarz T, Urbanski A, Kirnbauer R, Köck A, Gschnait F, Luger TA: Detection of a specific inhibitor of interleukin 1 in sera of UVB-treated mice. J Invest Dermatol 91: 536-540, 1988.
28. [28] Ullrich SE, McIntyre BW, Rivas JM: Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes. J Immunol 145: 489-498, 1990.
29. [29] Corradi A, Franzi AT, Rubartelli A: Synthesis and secretion of interleukin-1α and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes. Exp Cell Res 217: 355-362, 1995.
30. [30] Kondo S, Pastore S, Fujisawa H, Shivji GM, McKenzie RC, Dinarello CA, Sauder DN: Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol 105: 334-338, 1995.